Literature DB >> 10942800

Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors).

J A Breiner1, J Meis-Kindblom, L G Kindblom, E McComb, J Liu, M Nelson, J A Bridge.   

Abstract

Gastrointestinal stromal tumors (GISTs), also referred to as "gastrointestinal pacemaker cell tumors (GIPACT)" are mesenchymal neoplasms that are phenotypically similar to the interstitial cells of Cajal (ICC). Cytogenetic studies of this entity are rare and molecular cytogenetic studies utilizing chromosome-specific probes are nonexistent. In the current study, cytogenetic and molecular cytogenetic analysis of 12 histologically and immunohistochemically confirmed GISTs revealed loss of a whole chromosome 14 or region(s) of 14q in 8 tumors evaluated (67%) and loss of a whole chromosome 22 or region(s) of 22q in 8 (67%) patients. Loss of 14q and 22q were observed in histologically benign and malignant GISTs. Structural rearrangements of chromosome 1 were observed in 2 malignant GISTs. These findings indicate that loss of 14q and 22q are nonrandom, early events in GIST tumorigenesis and suggest that tumor suppressor genes responsible for the development of this neoplasm may be located on these chromosomal arms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942800     DOI: 10.1016/s0165-4608(00)00212-0

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  17 in total

1.  Concomitant Nonfunctional Pancreatic Neuroendocrine Tumor and Gastric GIST in a Patient Without Neurofibromatosis Type 1.

Authors:  Sven-Petter Haugvik; Bård Ingvald Røsok; Bjørn Edwin; Ivar Prydz Gladhaug; Øystein Mathisen
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  [Surgical considerations for gastrointestinal stroma tumor].

Authors:  P Hohenberger; E Wardelmann
Journal:  Chirurg       Date:  2006-01       Impact factor: 0.955

Review 3.  An update on molecular genetics of gastrointestinal stromal tumours.

Authors:  L Tornillo; L M Terracciano
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

4.  The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors.

Authors:  Johanna Andersson; Helene Sjögren; Jeanne M Meis-Kindblom; Göran Stenman; Pierre Aman; Lars-Gunnar Kindblom
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 5.  Current status of human chromosome 14.

Authors:  D Kamnasaran; D W Cox
Journal:  J Med Genet       Date:  2002-02       Impact factor: 6.318

Review 6.  [Gastrointestinal stromal tumors. A morphologic and molecular genetic independent tumor entity with new therapeutic perspectives].

Authors:  G Mechtersheimer; T Lehnert; R Penzel; S Joos; G Egerer; H F Otto
Journal:  Pathologe       Date:  2003-03-21       Impact factor: 1.011

Review 7.  Diagnostic procedures for submucosal tumors in the gastrointestinal tract.

Authors:  Laura-Graves Ponsaing; Katalin Kiss; Annika Loft; Lise-Ingemann Jensen; Mark-Berner Hansen
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

Review 8.  Management of resectable gastrointestinal stromal tumor.

Authors:  Umer I Chaudhry; Ronald P DeMatteo
Journal:  Hematol Oncol Clin North Am       Date:  2009-02       Impact factor: 3.722

9.  Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q.

Authors:  Hidetaka Yamamoto; Taro Tobo; Mari Nakamori; Masakazu Imamura; Aya Kojima; Yoshinao Oda; Norimoto Nakamura; Tomonari Takahira; Takashi Yao; Masazumi Tsuneyoshi
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-20       Impact factor: 4.553

10.  Succinate dehydrogenase deficiency in pediatric and adult gastrointestinal stromal tumors.

Authors:  Martin G Belinsky; Lori Rink; Margaret von Mehren
Journal:  Front Oncol       Date:  2013-05-17       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.